Global Reach assisTek has extensive clinical trial deployment across 40 countries, 46 languages, 6,500+ study sites, and 75,000+ patients, indicating strong international demand and opportunities to upsell or expand with new trial programs and multinational sponsors.

Integrated eSource The portfolio covers Site-Based eCOA, Field-Based ePRO, and Direct Clinical Data Capture with wireless, device-agnostic delivery on Android, presenting cross-sell potential to sponsors seeking end-to-end, mobile-friendly data capture solutions.

Recent Innovations Recent announcements include AI integration, a proprietary OS, SSO and remote provisioning, and CORE platform updates, signaling a roadmap that can be leveraged to address sponsors' needs for advanced analytics, security, and streamlined IT onboarding.

Financial Entry With reported revenue in the $1M–$10M range and a lean team, there is growth potential through larger sponsor deals, enterprise contracts, and broadened service offerings to capture larger trials and longer-term partnerships.

Crisis-Driven Value The 2020 web-based solution launch demonstrates agility in responding to disruptions, positioning assisTek as a reliable partner for sponsors prioritizing remote data capture, resiliency, and continuity of trial operations.